Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer

Clinical trial NCT05284539 · RECRUITING

Trial details

NCT number: NCT05284539
Sponsor: Hunan Province Tumor Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2022-04-01
Primary completion: 2026-09-30
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.